Governed by the Medicines and Related Substances Act (Act 101 of 1965), SAHPRA mandates regulatory clearance for all medical devices and In-Vitro Diagnostics entering South Africa. Compliance requires risk-based product classification across Classes A through D alongside a fully implemented ISO 13485 Quality Management System. Foreign manufacturers must appoint a local Authorized Representative (AR) residing in South Africa to manage regulatory communications and legal accountability.